Want to join the conversation?
$JNJ said Imbruvica has led the recent growth of its oncology franchise in the first-line chronic lymphocytic leukemia. Today, Imbruvica is reimbursed in 41 countries with world-class market access. Since launch an additional 6 indications have been approved and the company anticipates 7 new registrations, 4 of which have $500MM plus potential.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.